Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat walker carcinosarcoma following methotrexate pre-treatment: a 'F-MRS study in vivo
1992

Effects of Methotrexate on 5-Fluorouracil in Cancer Treatment

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): P.M.J. McSheehy, M.J.W. Prior, J.R. Griffiths

Primary Institution: CRC Biomedical Magnetic Resonance Research Group, Department of Cellular and Molecular Sciences, St. Georges Hospital Medical School

Hypothesis

Does methotrexate pre-treatment enhance the cytotoxic effects of 5-fluorouracil in the Walker carcinosarcoma model?

Conclusion

Methotrexate pre-treatment significantly increases the formation of cytotoxic nucleotides from 5-fluorouracil, enhancing its effectiveness against tumors.

Supporting Evidence

  • MTX pre-treatment increased FNuct formation by 3-fold.
  • 5-fluorouracil alone did not significantly inhibit tumor growth.
  • Combination therapy with MTX and 5-fluorouracil resulted in complete growth arrest.

Takeaway

Giving methotrexate before 5-fluorouracil helps the medicine work better against cancer.

Methodology

Rats with Walker carcinosarcoma were treated with methotrexate followed by 5-fluorouracil, and the formation of cytotoxic nucleotides was measured using 19F-MRS.

Limitations

The study was conducted in a rat model, which may not fully replicate human responses.

Participant Demographics

Female Wistar rats, weighing 180-220g.

Statistical Information

P-Value

p<0.002

Statistical Significance

p<0.002

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication